1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Insulin 1.2.3 SGLT-2 Inhibitors 1.2.4 Alpha-glucosidase Inhibitors 1.2.5 Others 1.3 Market by Application 1.3.1 Global Gestational Diabetes Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gestational Diabetes Treatment Market Perspective (2016-2027) 2.2 Gestational Diabetes Treatment Growth Trends by Regions 2.2.1 Gestational Diabetes Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gestational Diabetes Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Gestational Diabetes Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Gestational Diabetes Treatment Industry Dynamic 2.3.1 Gestational Diabetes Treatment Market Trends 2.3.2 Gestational Diabetes Treatment Market Drivers 2.3.3 Gestational Diabetes Treatment Market Challenges 2.3.4 Gestational Diabetes Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gestational Diabetes Treatment Players by Revenue 3.1.1 Global Top Gestational Diabetes Treatment Players by Revenue (2016-2021) 3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gestational Diabetes Treatment Revenue 3.4 Global Gestational Diabetes Treatment Market Concentration Ratio 3.4.1 Global Gestational Diabetes Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gestational Diabetes Treatment Revenue in 2020 3.5 Gestational Diabetes Treatment Key Players Head office and Area Served 3.6 Key Players Gestational Diabetes Treatment Product Solution and Service 3.7 Date of Enter into Gestational Diabetes Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gestational Diabetes Treatment Breakdown Data by Type 4.1 Global Gestational Diabetes Treatment Historic Market Size by Type (2016-2021) 4.2 Global Gestational Diabetes Treatment Forecasted Market Size by Type (2022-2027) 5 Gestational Diabetes Treatment Breakdown Data by Application 5.1 Global Gestational Diabetes Treatment Historic Market Size by Application (2016-2021) 5.2 Global Gestational Diabetes Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gestational Diabetes Treatment Market Size (2016-2027) 6.2 North America Gestational Diabetes Treatment Market Size by Type 6.2.1 North America Gestational Diabetes Treatment Market Size by Type (2016-2021) 6.2.2 North America Gestational Diabetes Treatment Market Size by Type (2022-2027) 6.2.3 North America Gestational Diabetes Treatment Market Size by Type (2016-2027) 6.3 North America Gestational Diabetes Treatment Market Size by Application 6.3.1 North America Gestational Diabetes Treatment Market Size by Application (2016-2021) 6.3.2 North America Gestational Diabetes Treatment Market Size by Application (2022-2027) 6.3.3 North America Gestational Diabetes Treatment Market Size by Application (2016-2027) 6.4 North America Gestational Diabetes Treatment Market Size by Country 6.4.1 North America Gestational Diabetes Treatment Market Size by Country (2016-2021) 6.4.2 North America Gestational Diabetes Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Gestational Diabetes Treatment Market Size (2016-2027) 7.2 Europe Gestational Diabetes Treatment Market Size by Type 7.2.1 Europe Gestational Diabetes Treatment Market Size by Type (2016-2021) 7.2.2 Europe Gestational Diabetes Treatment Market Size by Type (2022-2027) 7.2.3 Europe Gestational Diabetes Treatment Market Size by Type (2016-2027) 7.3 Europe Gestational Diabetes Treatment Market Size by Application 7.3.1 Europe Gestational Diabetes Treatment Market Size by Application (2016-2021) 7.3.2 Europe Gestational Diabetes Treatment Market Size by Application (2022-2027) 7.3.3 Europe Gestational Diabetes Treatment Market Size by Application (2016-2027) 7.4 Europe Gestational Diabetes Treatment Market Size by Country 7.4.1 Europe Gestational Diabetes Treatment Market Size by Country (2016-2021) 7.4.2 Europe Gestational Diabetes Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gestational Diabetes Treatment Market Size (2016-2027) 8.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type 8.2.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application 8.3.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Gestational Diabetes Treatment Market Size by Region 8.4.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gestational Diabetes Treatment Market Size (2016-2027) 9.2 Latin America Gestational Diabetes Treatment Market Size by Type 9.2.1 Latin America Gestational Diabetes Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Gestational Diabetes Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Gestational Diabetes Treatment Market Size by Type (2016-2027) 9.3 Latin America Gestational Diabetes Treatment Market Size by Application 9.3.1 Latin America Gestational Diabetes Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Gestational Diabetes Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Gestational Diabetes Treatment Market Size by Application (2016-2027) 9.4 Latin America Gestational Diabetes Treatment Market Size by Country 9.4.1 Latin America Gestational Diabetes Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Gestational Diabetes Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gestational Diabetes Treatment Market Size (2016-2027) 10.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type 10.2.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application 10.3.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Gestational Diabetes Treatment Market Size by Country 10.4.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biocon Limited 11.1.1 Biocon Limited Company Details 11.1.2 Biocon Limited Business Overview 11.1.3 Biocon Limited Gestational Diabetes Treatment Introduction 11.1.4 Biocon Limited Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.1.5 Biocon Limited Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Gestational Diabetes Treatment Introduction 11.2.4 Eli Lilly Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.2.5 Eli Lilly Recent Development 11.3 Novo Nordisk 11.3.1 Novo Nordisk Company Details 11.3.2 Novo Nordisk Business Overview 11.3.3 Novo Nordisk Gestational Diabetes Treatment Introduction 11.3.4 Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.3.5 Novo Nordisk Recent Development 11.4 Boehringer Ingelheim GmbH 11.4.1 Boehringer Ingelheim GmbH Company Details 11.4.2 Boehringer Ingelheim GmbH Business Overview 11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Introduction 11.4.4 Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.4.5 Boehringer Ingelheim GmbH Recent Development 11.5 Sanofi S.A. 11.5.1 Sanofi S.A. Company Details 11.5.2 Sanofi S.A. Business Overview 11.5.3 Sanofi S.A. Gestational Diabetes Treatment Introduction 11.5.4 Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.5.5 Sanofi S.A. Recent Development 11.6 Sun Pharmaceutical Industries Limited 11.6.1 Sun Pharmaceutical Industries Limited Company Details 11.6.2 Sun Pharmaceutical Industries Limited Business Overview 11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Introduction 11.6.4 Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.6.5 Sun Pharmaceutical Industries Limited Recent Development 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck Gestational Diabetes Treatment Introduction 11.7.4 Merck Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.7.5 Merck Recent Development 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview 11.8.3 Novartis Gestational Diabetes Treatment Introduction 11.8.4 Novartis Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.8.5 Novartis Recent Development 11.9 Adocia 11.9.1 Adocia Company Details 11.9.2 Adocia Business Overview 11.9.3 Adocia Gestational Diabetes Treatment Introduction 11.9.4 Adocia Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.9.5 Adocia Recent Development 11.10 Peptron 11.10.1 Peptron Company Details 11.10.2 Peptron Business Overview 11.10.3 Peptron Gestational Diabetes Treatment Introduction 11.10.4 Peptron Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.10.5 Peptron Recent Development 11.11 AstraZeneca plc 11.11.1 AstraZeneca plc Company Details 11.11.2 AstraZeneca plc Business Overview 11.11.3 AstraZeneca plc Gestational Diabetes Treatment Introduction 11.11.4 AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.11.5 AstraZeneca plc Recent Development 11.12 Pfizer, Inc 11.12.1 Pfizer, Inc Company Details 11.12.2 Pfizer, Inc Business Overview 11.12.3 Pfizer, Inc Gestational Diabetes Treatment Introduction 11.12.4 Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.12.5 Pfizer, Inc Recent Development 11.13 Takeda Pharmaceutical Company Ltd 11.13.1 Takeda Pharmaceutical Company Ltd Company Details 11.13.2 Takeda Pharmaceutical Company Ltd Business Overview 11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Introduction 11.13.4 Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.13.5 Takeda Pharmaceutical Company Ltd Recent Development 11.14 Abbott 11.14.1 Abbott Company Details 11.14.2 Abbott Business Overview 11.14.3 Abbott Gestational Diabetes Treatment Introduction 11.14.4 Abbott Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.14.5 Abbott Recent Development 11.15 Antares Pharma 11.15.1 Antares Pharma Company Details 11.15.2 Antares Pharma Business Overview 11.15.3 Antares Pharma Gestational Diabetes Treatment Introduction 11.15.4 Antares Pharma Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.15.5 Antares Pharma Recent Development 11.16 INJEX Pharma AG 11.16.1 INJEX Pharma AG Company Details 11.16.2 INJEX Pharma AG Business Overview 11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Introduction 11.16.4 INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.16.5 INJEX Pharma AG Recent Development 11.17 Daiichi Sankyo 11.17.1 Daiichi Sankyo Company Details 11.17.2 Daiichi Sankyo Business Overview 11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Introduction 11.17.4 Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2016-2021) 11.17.5 Daiichi Sankyo Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gestational Diabetes Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Insulin Table 3. Key Players of SGLT-2 Inhibitors Table 4. Key Players of Alpha-glucosidase Inhibitors Table 5. Key Players of Others Table 6. Global Gestational Diabetes Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Gestational Diabetes Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Gestational Diabetes Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Gestational Diabetes Treatment Market Share by Regions (2016-2021) Table 10. Global Gestational Diabetes Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Gestational Diabetes Treatment Market Share by Regions (2022-2027) Table 12. Gestational Diabetes Treatment Market Trends Table 13. Gestational Diabetes Treatment Market Drivers Table 14. Gestational Diabetes Treatment Market Challenges Table 15. Gestational Diabetes Treatment Market Restraints Table 16. Global Gestational Diabetes Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Gestational Diabetes Treatment Market Share by Players (2016-2021) Table 18. Global Top Gestational Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gestational Diabetes Treatment as of 2020) Table 19. Ranking of Global Top Gestational Diabetes Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Gestational Diabetes Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Gestational Diabetes Treatment Product Solution and Service Table 23. Date of Enter into Gestational Diabetes Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Gestational Diabetes Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Gestational Diabetes Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Gestational Diabetes Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Gestational Diabetes Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Gestational Diabetes Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Gestational Diabetes Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Gestational Diabetes Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Gestational Diabetes Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Gestational Diabetes Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Gestational Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Gestational Diabetes Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Gestational Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Gestational Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Gestational Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Gestational Diabetes Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Gestational Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Gestational Diabetes Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Gestational Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Gestational Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Gestational Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Gestational Diabetes Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Gestational Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Gestational Diabetes Treatment Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Gestational Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Gestational Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Gestational Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Biocon Limited Company Details Table 64. Biocon Limited Business Overview Table 65. Biocon Limited Gestational Diabetes Treatment Product Table 66. Biocon Limited Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 67. Biocon Limited Recent Development Table 68. Eli Lilly Company Details Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Gestational Diabetes Treatment Product Table 71. Eli Lilly Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 72. Eli Lilly Recent Development Table 73. Novo Nordisk Company Details Table 74. Novo Nordisk Business Overview Table 75. Novo Nordisk Gestational Diabetes Treatment Product Table 76. Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 77. Novo Nordisk Recent Development Table 78. Boehringer Ingelheim GmbH Company Details Table 79. Boehringer Ingelheim GmbH Business Overview Table 80. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Table 81. Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 82. Boehringer Ingelheim GmbH Recent Development Table 83. Sanofi S.A. Company Details Table 84. Sanofi S.A. Business Overview Table 85. Sanofi S.A. Gestational Diabetes Treatment Product Table 86. Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 87. Sanofi S.A. Recent Development Table 88. Sun Pharmaceutical Industries Limited Company Details Table 89. Sun Pharmaceutical Industries Limited Business Overview Table 90. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Table 91. Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 92. Sun Pharmaceutical Industries Limited Recent Development Table 93. Merck Company Details Table 94. Merck Business Overview Table 95. Merck Gestational Diabetes Treatment Product Table 96. Merck Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 97. Merck Recent Development Table 98. Novartis Company Details Table 99. Novartis Business Overview Table 100. Novartis Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 101. Novartis Recent Development Table 102. Adocia Company Details Table 103. Adocia Business Overview Table 104. Adocia Gestational Diabetes Treatment Product Table 105. Adocia Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 106. Adocia Recent Development Table 107. Peptron Company Details Table 108. Peptron Business Overview Table 109. Peptron Gestational Diabetes Treatment Product Table 110. Peptron Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 111. Peptron Recent Development Table 112. AstraZeneca plc Company Details Table 113. AstraZeneca plc Business Overview Table 114. AstraZeneca plc Gestational Diabetes Treatment Product Table 115. AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 116. AstraZeneca plc Recent Development Table 117. Pfizer, Inc Company Details Table 118. Pfizer, Inc Business Overview Table 119. Pfizer, Inc Gestational Diabetes Treatment Product Table 120. Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 121. Pfizer, Inc Recent Development Table 122. Takeda Pharmaceutical Company Ltd Company Details Table 123. Takeda Pharmaceutical Company Ltd Business Overview Table 124. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Table 125. Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 126. Takeda Pharmaceutical Company Ltd Recent Development Table 127. Abbott Company Details Table 128. Abbott Business Overview Table 129. Abbott Gestational Diabetes Treatment Product Table 130. Abbott Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 131. Abbott Recent Development Table 132. Antares Pharma Company Details Table 133. Antares Pharma Business Overview Table 134. Antares Pharma Gestational Diabetes Treatment Product Table 135. Antares Pharma Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 136. Antares Pharma Recent Development Table 137. INJEX Pharma AG Company Details Table 138. INJEX Pharma AG Business Overview Table 139. INJEX Pharma AG Gestational Diabetes Treatment Product Table 140. INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 141. INJEX Pharma AG Recent Development Table 142. Daiichi Sankyo Company Details Table 143. Daiichi Sankyo Business Overview Table 144. Daiichi Sankyo Gestational Diabetes Treatment Product Table 145. Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2016-2021) & (US$ Million) Table 146. Daiichi Sankyo Recent Development Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Global Gestational Diabetes Treatment Market Share by Type: 2020 VS 2027 Figure 2. Insulin Features Figure 3. SGLT-2 Inhibitors Features Figure 4. Alpha-glucosidase Inhibitors Features Figure 5. Others Features Figure 6. Global Gestational Diabetes Treatment Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Gestational Diabetes Treatment Report Years Considered Figure 11. Global Gestational Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Gestational Diabetes Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Gestational Diabetes Treatment Market Share by Regions: 2020 VS 2027 Figure 14. Global Gestational Diabetes Treatment Market Share by Regions (2022-2027) Figure 15. Global Gestational Diabetes Treatment Market Share by Players in 2020 Figure 16. Global Top Gestational Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gestational Diabetes Treatment as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Gestational Diabetes Treatment Revenue in 2020 Figure 18. Global Gestational Diabetes Treatment Revenue Market Share by Type (2016-2021) Figure 19. Global Gestational Diabetes Treatment Revenue Market Share by Type (2022-2027) Figure 20. North America Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Gestational Diabetes Treatment Market Share by Type (2016-2027) Figure 22. North America Gestational Diabetes Treatment Market Share by Application (2016-2027) Figure 23. North America Gestational Diabetes Treatment Market Share by Country (2016-2027) Figure 24. United States Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Gestational Diabetes Treatment Market Share by Type (2016-2027) Figure 28. Europe Gestational Diabetes Treatment Market Share by Application (2016-2027) Figure 29. Europe Gestational Diabetes Treatment Market Share by Country (2016-2027) Figure 30. Germany Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Gestational Diabetes Treatment Market Share by Type (2016-2027) Figure 38. Asia-Pacific Gestational Diabetes Treatment Market Share by Application (2016-2027) Figure 39. Asia-Pacific Gestational Diabetes Treatment Market Share by Region (2016-2027) Figure 40. China Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Gestational Diabetes Treatment Market Share by Type (2016-2027) Figure 48. Latin America Gestational Diabetes Treatment Market Share by Application (2016-2027) Figure 49. Latin America Gestational Diabetes Treatment Market Share by Country (2016-2027) Figure 50. Mexico Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Gestational Diabetes Treatment Market Share by Type (2016-2027) Figure 54. Middle East & Africa Gestational Diabetes Treatment Market Share by Application (2016-2027) Figure 55. Middle East & Africa Gestational Diabetes Treatment Market Share by Country (2016-2027) Figure 56. Turkey Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Gestational Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Biocon Limited Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 60. Eli Lilly Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 61. Novo Nordisk Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 62. Boehringer Ingelheim GmbH Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 63. Sanofi S.A. Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 64. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 65. Merck Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 66. Novartis Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 67. Adocia Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 68. Peptron Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 69. AstraZeneca plc Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 70. Pfizer, Inc Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 71. Takeda Pharmaceutical Company Ltd Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 72. Abbott Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 73. Antares Pharma Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 74. INJEX Pharma AG Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 75. Daiichi Sankyo Revenue Growth Rate in Gestational Diabetes Treatment Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Biocon Limited Eli Lilly Novo Nordisk Boehringer Ingelheim GmbH Sanofi S.A. Sun Pharmaceutical Industries Limited Merck Novartis Adocia Peptron AstraZeneca plc Pfizer, Inc Takeda Pharmaceutical Company Ltd Abbott Antares Pharma INJEX Pharma AG Daiichi Sankyo